6-KThe Wire
TAKEDA PHARMACEUTICAL CO LTD files 6-K
Filed Jun 26, 2026 · 7d ago · Accession 0001395064-26-000187
Plain English
Takeda Pharmaceutical Company Limited held its 150th Annual General Meeting of Shareholders on June 26, 2026, where shareholders voted on various proposals. The results of the exercise of voting rights for these proposals are detailed in the filing.
Filing details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Ticker
- TAK
- CIK
- 1395064
- Form type
- 6-K
- Filing date
- Jun 26, 2026
- Report date
- Jun 26, 2026
- Document
- form6k_062626.htm
- Size
- 505 KB